Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
about
Infected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniaeTreatment of bacterial meningitis.Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitisComparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children witEvaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.Antibiotic susceptibility patterns of Streptococcus pneumoniae in china and comparison of MICs by agar dilution and E-test methods.In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia modelLumbar vertebral osteomyelitis with mycotic abdominal aortic aneurysm caused by highly penicillin-resistant Streptococcus pneumoniae.Impact of antimicrobial agents and chemotherapy from 1972 to 1998.Management of infections due to antibiotic-resistant Streptococcus pneumoniaePharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically acFractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.Bacterial Meningitis: Principles and Practical Aspects of Therapy.The antibiotic and anti-inflammatory treatment of bacterial meningitis in adults: do we have to change our strategies in an era of increasing antibiotic resistance?Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitisBactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin.High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporinsAntipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methodsComparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes.A review of the current place of glycopeptides in turkish medical practiceCerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.Diagnosis and treatment of bacterial meningitis.Increasing chloramphenicol resistance in Streptococcus pneumoniae isolates from Papua New Guinean children with acute bacterial meningitis.Activity of vancomycin, teicoplanin and cephalosporins against penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae.Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.Gram-positive cocci infections in intensive care: guide to antibacterial selection.Current concepts in the treatment of bacterial meningitis beyond the neonatal period.Acute bacterial meningitis in infants and children: epidemiology and management.Treatment of bacterial meningitis: an update.Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model
P2860
Q28378935-7DF7F0B1-80FF-4D3C-A640-ED3437135942Q33544695-58AACFD9-BA73-4BD5-A4BF-C94225FBCAD1Q33654490-D8F44583-A5A0-4C53-96B3-D5523C3172DEQ33692927-FCE644ED-798C-4CD0-B97E-D88534915CC6Q33694143-A61B0E90-E03A-41D1-A40D-C19D957DAFC7Q33699406-A444D384-9578-4725-BAE1-DC417C028FD0Q33757851-2C501D71-DAC5-481E-BC2E-513D58BC5DCEQ33964464-AB8DEF4D-34CB-4904-AC7C-24C5E8ED9B3CQ33970709-101806DC-F1DB-43A5-91AF-350A93A0A283Q33975374-2ECC5C8E-7425-4BE5-9E4B-2625184C5026Q33976683-24CC6942-E35A-4318-84B4-2D62469C4795Q33977786-3AD6CDEA-ABAF-40DE-B22A-3C49B2E14982Q33983513-24D530F4-847D-48C3-BA18-80AB273F94BAQ34092272-EE68599B-A8C3-44C5-8366-9FC0C515BDA5Q34402548-6CC1E3F2-65A3-4456-99CE-719BE4471BA9Q34719869-78EE7E8A-A4E9-46D6-B609-07218AD1C674Q34720054-6CAEF1ED-3961-4800-997D-930239FCCB27Q35013994-DCDD0132-803F-4050-A87C-147BFF8AE9B8Q35118221-C8F7DC57-DDF2-4CE1-A131-142D888BA4B9Q35119049-BF2FC272-1B18-4406-BFC6-5520F3B9AC00Q35120392-AF243592-F8DE-4DA4-AE29-49A595C9C224Q35121060-704BF6C9-0BBF-4B1C-BBF3-B67ED06A60A0Q35122014-8C6C25CC-0408-42C5-86B6-548B9926FD8EQ35126435-9AB5E82A-5E3E-4BE1-8354-7681F26E0487Q35130937-3B36C4E3-69EA-4B65-877F-440CF8CD2FFBQ35134138-2701D2E4-A8FB-456D-8CA8-C5AFD5319BDDQ35137976-ECDCF8CB-633C-48F4-AAE9-B5D2622E99D2Q35138302-89CD3F93-FE56-4456-A0A7-920A1D3A720BQ35138311-109F4005-8B10-4BF0-827F-FB28BEEA74D6Q35159286-EC4CCDE6-859B-41D3-944B-A45DA79AC98AQ35191559-45F84548-B7CE-4D96-9F9F-F66409B25A61Q35816735-34FD9875-CE8B-4AA5-9FB7-6FD9776F4ABCQ35820094-A26BBC90-E994-43B5-B54A-B5C25E928982Q35821585-19C860BE-0C24-4D60-82F6-0C59606FC6AAQ35822592-6E80D2C0-4BA7-4B4E-9FE2-8C435532C93DQ36480958-8FDFACE6-7499-458F-AEAA-85937ED93772Q36607421-7759197D-2DAB-46E3-914B-9D01B87370F4Q37945754-48754DCE-6211-490E-AD6D-A91C77013B20Q38044024-7449EC96-2F52-4EC6-A5D2-14D040F801C2Q39470648-7D92B7BF-1600-48AB-81E0-1CF3C60B9EF8
P2860
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Evaluation of antimicrobial re ...... stant pneumococcal meningitis.
@ast
Evaluation of antimicrobial re ...... stant pneumococcal meningitis.
@en
type
label
Evaluation of antimicrobial re ...... stant pneumococcal meningitis.
@ast
Evaluation of antimicrobial re ...... stant pneumococcal meningitis.
@en
prefLabel
Evaluation of antimicrobial re ...... stant pneumococcal meningitis.
@ast
Evaluation of antimicrobial re ...... stant pneumococcal meningitis.
@en
P2093
P2860
P356
P1476
Evaluation of antimicrobial re ...... stant pneumococcal meningitis.
@en
P2093
P2860
P304
P356
10.1128/AAC.37.8.1630
P407
P577
1993-08-01T00:00:00Z